102 results
Page 3 of 6
8-K
EX-99.1
8alg08t
30 Apr 20
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations andCOVID-19 Response
7:19am
DEFA14A
6ayq 23a7hx79jflx6y
16 Apr 20
Additional proxy soliciting materials
4:04pm
8-K
EX-1.1
3uc8rkob
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
8-K
EX-99.1
3bg 48jfeolt4
2 May 19
Other Events
3:24pm
DEFA14A
v5cfd
18 Apr 19
Additional proxy soliciting materials
4:07pm
8-K
EX-3.1
tnop24bm6k
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.1
kyar1165zih 34h
20 Jul 18
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients
11:21am
8-K
EX-99.2
ljp24pk8wagh 9mhzha
4 May 18
Results of Operations and Financial Condition
7:07am